Interleukin Genetics Inc's ticker is ILIU and the CUSIP is 458738101.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $1,000 | -97.4% | 302,271 | -75.3% | 0.00% | -100.0% |
Q3 2017 | $38,000 | +5.6% | 1,222,864 | +100.0% | 0.01% | +12.5% |
Q2 2017 | $36,000 | -47.8% | 611,432 | 0.0% | 0.01% | -50.0% |
Q1 2017 | $69,000 | -42.0% | 611,432 | 0.0% | 0.02% | -38.5% |
Q3 2016 | $119,000 | +50.6% | 611,432 | 0.0% | 0.03% | +44.4% |
Q2 2016 | $79,000 | +17.9% | 611,432 | 0.0% | 0.02% | +20.0% |
Q1 2016 | $67,000 | +86.1% | 611,432 | 0.0% | 0.02% | +114.3% |
Q4 2015 | $36,000 | -26.5% | 611,432 | 0.0% | 0.01% | -36.4% |
Q3 2015 | $49,000 | +6.5% | 611,432 | +71.5% | 0.01% | 0.0% |
Q2 2015 | $46,000 | +9.5% | 356,432 | +17.9% | 0.01% | -8.3% |
Q1 2015 | $42,000 | 0.0% | 302,271 | 0.0% | 0.01% | 0.0% |
Q4 2014 | $42,000 | -6.7% | 302,271 | 0.0% | 0.01% | -25.0% |
Q3 2014 | $45,000 | -50.5% | 302,271 | 0.0% | 0.02% | -51.5% |
Q2 2014 | $91,000 | -14.2% | 302,271 | 0.0% | 0.03% | -19.5% |
Q1 2014 | $106,000 | 0.0% | 302,271 | 0.0% | 0.04% | 0.0% |
Q4 2013 | $106,000 | -16.5% | 302,271 | 0.0% | 0.04% | -21.2% |
Q3 2013 | $127,000 | 0.0% | 302,271 | 0.0% | 0.05% | 0.0% |
Q2 2013 | $127,000 | -15.9% | 302,271 | 0.0% | 0.05% | -17.5% |
Q1 2013 | $151,000 | +60.6% | 302,271 | 0.0% | 0.06% | +50.0% |
Q4 2012 | $94,000 | -26.0% | 302,271 | 0.0% | 0.04% | -25.0% |
Q3 2012 | $127,000 | +54.9% | 302,271 | 0.0% | 0.06% | +55.6% |
Q2 2012 | $82,000 | -9.9% | 302,271 | 0.0% | 0.04% | -12.2% |
Q1 2012 | $91,000 | +2933.3% | 302,271 | +1884.2% | 0.04% | +1950.0% |
Q4 2011 | $3,000 | – | 15,234 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|